Premium
Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)
Author(s) -
Me Lalitha L.,
Chin Beatrice,
Khattak Muhammad A.
Publication year - 2018
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.14131
Subject(s) - medicine , family medicine , pembrolizumab , library science , cancer , computer science , immunotherapy